Trajectories of suicidal ideation during 12 weeks of escitalopram or nortriptyline antidepressant treatment among 811 patients with major depressive disorder

• Verfasst von: Madsen, Trine [VerfasserIn]
• Verfasst von: Rietschel, Marcella [VerfasserIn]
• Titel: Trajectories of suicidal ideation during 12 weeks of escitalopram or nortriptyline antidepressant treatment among 811 patients with major depressive disorder
• Verf.angabe: Trine Madsen, Henriette N. Buttenschøn, Rudolf Uher, Ida Behrendt-Møller, Nader Perroud, Wolfgang Maier, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Marcella Rietschel, Peter McGuffin, Katherine J. Aitchison, Ole Mors, and Ole Köhler-Forsberg
• Jahr: 2019
• Umfang: 7 S.
• Fussnoten: Gesehen am 21.01.2020
• Titel Quelle: Enthalten in: The journal of clinical psychiatry
• Ort Quelle: Memphis, Tenn. : Physicians Postgraduate Press, 1996
• Jahr Quelle: 2019
• Band/Heft Quelle: 80(2019,4) Artikel-Nummer 18m12575, 7 Seiten
• ISSN Quelle: 1555-2101
• DOI: doi:10.4088/JCP.18m12575
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1687956383

Abstract

Background: Suicidal ideation is a frequent and difficult-to-treat clinical challenge among patients with major depressive disorder (MDD). However, little is known regarding the differential development during antidepressant treatment and whether some patients may suffer from persistent suicidal ideation. Methods: Among 811 patients with Schedules for Clinical Assessment in Neuropsychiatry (SCAN)–verified MDD from 2004–2007 assessed weekly for 12 weeks of escitalopram or nortriptyline antidepressant treatment, we applied item response theory to integrate a suicidality score based on 3 rating scales. We performed latent growth mixture modeling analysis to empirically identify trajectories. Multinomial logistic regression analyses estimated associations with potential predictors. Results: We identified 5 distinct classes of suicidal ideation. The Persistent-low class (53.7%) showed no suicidal ideation whereas the Persistent-high class (9.8%) had high suicidal ideation throughout 12 weeks. Two classes showed a fluctuating course: the Fluctuating class (5.2%) ended at a low level of suicidal ideation, whereas the Slow-response-relapse class (4.8%) initially responded slowly but then experienced a large increase to a high level of suicidal ideation after 12 weeks. The Fast-response class (26.5%) had a high baseline severity similar to the Persistent-high class but responded quickly within a few weeks and remained at a low level. Previous suicide attempts and higher mood symptom severity were associated with worse suicidal ideation trajectories, whereas living with a partner showed a trend toward better response. Conclusion: Approximately 1 of 5 patients with MDD showed high or fluctuating suicidal ideation despite antidepressant treatment. Studies should investigate whether suicidal ideation may persist for longer periods and more targeted treatment possibilities.